Watertime, Author at PsyNews.com

Home Authors Posts by Watertime

111 POSTS 0 COMMENTS

atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate...

atai Life Sciences to Host Conference Call and Webcast to Discuss...

atai Life Sciences Has Been Selected for Addition to the NASDAQ...

atai Life Sciences Increases its Ownership Position in COMPASS Pathways

The Psilocybin Supply Chain: An Evidence-Based Review

Psygen Industries Ltd letter to Health Canada re: SAP

The Psychedelic News Feed: September 2, 2024 – December 29, 2024

Psychedelic Drug Development Pipeline Updates (Q1’25)

Q1’25 Psychedelic Drug Development Pipeline: Bullseye Chart

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Watertime

atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate...

atai Life Sciences to Host Conference Call and Webcast to Discuss...

atai Life Sciences Has Been Selected for Addition to the NASDAQ...

atai Life Sciences Increases its Ownership Position in COMPASS Pathways

July 2020 Newsletter

Sept/Oct 2020 Newsletter

The Psilocybin Supply Chain: An Evidence-Based Review

June 2020 Newsletter

Psygen Industries Ltd letter to Health Canada re: SAP

November 2020 Newsletter

EDITOR PICKS

The Psychedelic News Feed: September 2, 2024 – December 29, 2024

Psychedelic Drug Development Pipeline Updates (Q1’25)

Q1’25 Psychedelic Drug Development Pipeline: Bullseye Chart

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY